548 related articles for article (PubMed ID: 36115361)
1. Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study.
Hobeanu C; Lavallée PC; Charles H; Labreuche J; Albers GW; Caplan LR; Donnan GA; Ferro JM; Hennerici MG; Molina CA; Rothwell PM; Steg PG; Touboul PJ; Uchiyama S; Vicaut E; Wong KSL; Amarenco P;
Lancet Neurol; 2022 Oct; 21(10):889-898. PubMed ID: 36115361
[TBL] [Abstract][Full Text] [Related]
2. Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study.
Lavallée PC; Charles H; Albers GW; Caplan LR; Donnan GA; Ferro JM; Hennerici MG; Labreuche J; Molina C; Rothwell PM; Steg PG; Touboul PJ; Uchiyama S; Vicaut É; Wong LKS; Amarenco P;
Lancet Neurol; 2023 Apr; 22(4):320-329. PubMed ID: 36931807
[TBL] [Abstract][Full Text] [Related]
3. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
Wilson D; Ambler G; Shakeshaft C; Brown MM; Charidimou A; Al-Shahi Salman R; Lip GYH; Cohen H; Banerjee G; Houlden H; White MJ; Yousry TA; Harkness K; Flossmann E; Smyth N; Shaw LJ; Warburton E; Muir KW; Jäger HR; Werring DJ;
Lancet Neurol; 2018 Jun; 17(6):539-547. PubMed ID: 29778365
[TBL] [Abstract][Full Text] [Related]
4. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study.
Pendlebury ST; Rothwell PM;
Lancet Neurol; 2019 Mar; 18(3):248-258. PubMed ID: 30784556
[TBL] [Abstract][Full Text] [Related]
5. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
Wilson D; Ambler G; Lee KJ; Lim JS; Shiozawa M; Koga M; Li L; Lovelock C; Chabriat H; Hennerici M; Wong YK; Mak HKF; Prats-Sánchez L; Martínez-Domeño A; Inamura S; Yoshifuji K; Arsava EM; Horstmann S; Purrucker J; Lam BYK; Wong A; Kim YD; Song TJ; Schrooten M; Lemmens R; Eppinger S; Gattringer T; Uysal E; Tanriverdi Z; Bornstein NM; Assayag EB; Hallevi H; Tanaka J; Hara H; Coutts SB; Hert L; Polymeris A; Seiffge DJ; Lyrer P; Algra A; Kappelle J; Al-Shahi Salman R; Jäger HR; Lip GYH; Mattle HP; Panos LD; Mas JL; Legrand L; Karayiannis C; Phan T; Gunkel S; Christ N; Abrigo J; Leung T; Chu W; Chappell F; Makin S; Hayden D; Williams DJ; Kooi ME; van Dam-Nolen DHK; Barbato C; Browning S; Wiegertjes K; Tuladhar AM; Maaijwee N; Guevarra C; Yatawara C; Mendyk AM; Delmaire C; Köhler S; van Oostenbrugge R; Zhou Y; Xu C; Hilal S; Gyanwali B; Chen C; Lou M; Staals J; Bordet R; Kandiah N; de Leeuw FE; Simister R; van der Lugt A; Kelly PJ; Wardlaw JM; Soo Y; Fluri F; Srikanth V; Calvet D; Jung S; Kwa VIH; Engelter ST; Peters N; Smith EE; Yakushiji Y; Orken DN; Fazekas F; Thijs V; Heo JH; Mok V; Veltkamp R; Ay H; Imaizumi T; Gomez-Anson B; Lau KK; Jouvent E; Rothwell PM; Toyoda K; Bae HJ; Marti-Fabregas J; Werring DJ;
Lancet Neurol; 2019 Jul; 18(7):653-665. PubMed ID: 31130428
[TBL] [Abstract][Full Text] [Related]
6. Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials.
Rothwell PM; Algra A; Chen Z; Diener HC; Norrving B; Mehta Z
Lancet; 2016 Jul; 388(10042):365-375. PubMed ID: 27209146
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial.
Amarenco P; Denison H; Evans SR; Himmelmann A; James S; Knutsson M; Ladenvall P; Molina CA; Wang Y; Johnston SC;
JAMA Neurol; 2020 Nov; 78(2):1-9. PubMed ID: 33159526
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial.
Mehra MR; Vaduganathan M; Fu M; Ferreira JP; Anker SD; Cleland JGF; Lam CSP; van Veldhuisen DJ; Byra WM; Spiro TE; Deng H; Zannad F; Greenberg B
Eur Heart J; 2019 Nov; 40(44):3593-3602. PubMed ID: 31461239
[TBL] [Abstract][Full Text] [Related]
9. Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial.
Cucchiara B; Elm J; Easton JD; Coutts SB; Willey JZ; Biros MH; Ross MA; Johnston SC
Stroke; 2020 Mar; 51(3):792-799. PubMed ID: 32078486
[TBL] [Abstract][Full Text] [Related]
10. Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
Best JG; Ambler G; Wilson D; Lee KJ; Lim JS; Shiozawa M; Koga M; Li L; Lovelock C; Chabriat H; Hennerici M; Wong YK; Mak HKF; Prats-Sanchez L; Martínez-Domeño A; Inamura S; Yoshifuji K; Arsava EM; Horstmann S; Purrucker J; Lam BYK; Wong A; Kim YD; Song TJ; Lemmens R; Eppinger S; Gattringer T; Uysal E; Tanriverdi Z; Bornstein NM; Ben Assayag E; Hallevi H; Molad J; Nishihara M; Tanaka J; Coutts SB; Polymeris A; Wagner B; Seiffge DJ; Lyrer P; Algra A; Kappelle LJ; Al-Shahi Salman R; Jäger HR; Lip GYH; Fischer U; El-Koussy M; Mas JL; Legrand L; Karayiannis C; Phan T; Gunkel S; Christ N; Abrigo J; Leung T; Chu W; Chappell F; Makin S; Hayden D; Williams DJ; Mess WH; Nederkoorn PJ; Barbato C; Browning S; Wiegertjes K; Tuladhar AM; Maaijwee N; Guevarra AC; Yatawara C; Mendyk AM; Delmaire C; Köhler S; van Oostenbrugge R; Zhou Y; Xu C; Hilal S; Gyanwali B; Chen C; Lou M; Staals J; Bordet R; Kandiah N; de Leeuw FE; Simister R; Hendrikse J; Kelly PJ; Wardlaw J; Soo Y; Fluri F; Srikanth V; Calvet D; Jung S; Kwa VIH; Engelter ST; Peters N; Smith EE; Hara H; Yakushiji Y; Orken DN; Fazekas F; Thijs V; Heo JH; Mok V; Veltkamp R; Ay H; Imaizumi T; Gomez-Anson B; Lau KK; Jouvent E; Rothwell PM; Toyoda K; Bae HJ; Marti-Fabregas J; Werring DJ;
Lancet Neurol; 2021 Apr; 20(4):294-303. PubMed ID: 33743239
[TBL] [Abstract][Full Text] [Related]
11. A support programme for secondary prevention in patients with transient ischaemic attack and minor stroke (INSPiRE-TMS): an open-label, randomised controlled trial.
Ahmadi M; Laumeier I; Ihl T; Steinicke M; Ferse C; Endres M; Grau A; Hastrup S; Poppert H; Palm F; Schoene M; Seifert CL; Kandil FI; Weber JE; von Weitzel-Mudersbach P; Wimmer MLJ; Algra A; Amarenco P; Greving JP; Busse O; Köhler F; Marx P; Audebert HJ
Lancet Neurol; 2020 Jan; 19(1):49-60. PubMed ID: 31708447
[TBL] [Abstract][Full Text] [Related]
12. Demographics, socio-economic characteristics, and risk factor prevalence in patients with non-cardioembolic ischaemic stroke in low- and middle-income countries: the OPTIC registry.
Abboud H; Labreuche J; Arauz A; Bryer A; Lavados PG; Massaro A; Munoz Collazos M; Steg PG; Yamout BI; Vicaut E; Amarenco P;
Int J Stroke; 2013 Oct; 8 Suppl A100():4-13. PubMed ID: 22974118
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study.
Hurford R; Wolters FJ; Li L; Lau KK; Küker W; Rothwell PM;
Lancet Neurol; 2020 May; 19(5):413-421. PubMed ID: 32333899
[TBL] [Abstract][Full Text] [Related]
14. What causes disability after transient ischemic attack and minor stroke?: Results from the CT and MRI in the Triage of TIA and minor Cerebrovascular Events to Identify High Risk Patients (CATCH) Study.
Coutts SB; Modi J; Patel SK; Aram H; Demchuk AM; Goyal M; Hill MD
Stroke; 2012 Nov; 43(11):3018-22. PubMed ID: 22984013
[TBL] [Abstract][Full Text] [Related]
15. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.
Hippisley-Cox J; Coupland C; Brindle P
BMJ; 2013 May; 346():f2573. PubMed ID: 23641033
[TBL] [Abstract][Full Text] [Related]
16. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study.
Li L; Yiin GS; Geraghty OC; Schulz UG; Kuker W; Mehta Z; Rothwell PM;
Lancet Neurol; 2015 Sep; 14(9):903-913. PubMed ID: 26227434
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and prognosis in oldest old patients with ischaemic stroke or transient ischaemic attack in China.
Wang Y; Jing J; Pan Y; Wang M; Meng X; Wang Y
Ann Palliat Med; 2022 Jul; 11(7):2215-2224. PubMed ID: 35272470
[TBL] [Abstract][Full Text] [Related]
18. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of non-consensus transient ischaemic attacks with focal, negative, and non-progressive symptoms: population-based validation by investigation and prognosis.
Tuna MA; Rothwell PM;
Lancet; 2021 Mar; 397(10277):902-912. PubMed ID: 33676629
[TBL] [Abstract][Full Text] [Related]
20. Oxidative lipoprotein markers predict poor functional outcome in patients with minor stroke or transient ischaemic attack.
Wang A; Zhang X; Li S; Zhao X; Liu L; Johnston SC; Meng X; Lin J; Zuo Y; Li H; Wang Y; Wang Y;
Eur J Neurol; 2019 Aug; 26(8):1082-1090. PubMed ID: 30793440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
